KVP Capital Advisors »

Aadi Bioscience shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Aadi Bioscience (WHWK) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Aadi Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Aadi Bioscience held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aadi Bioscience by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.2M 2.2M 2.42

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Aadi Bioscience

QVT Financial
OrbiMed Advisors
Suvretta Capital Management
Longwood Capital Partners
venBio Select Advisor
KVP Capital Advisors
Siren
Yu Fan
Vanguard Group
Acorn Capital Advisors
Ally Bridge Group
Renaissance Technologies
Geode Capital Management
Stempoint Capital
BlackRock

View all funds holding Aadi Bioscience